08:00 , Jan 28, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Indication

Indication Target/marker/pathway Summary Licensing status Publication and contact information Transplantation Graft-versus-host disease (GvHD) Peptidase inhibitor 3 skin-derived (PI3; elafin) A study in patient samples suggests that elafin...